Abstract:Background: Throughout a patient's course of radiation therapy, maintaining accuracy of their initial treatment plan over time is challenging due to anatomical changes-for example, stemming from patient weight loss or tumor shrinkage. Online adaptation of their RT plan to these changes is crucial, but hindered by manual and time-consuming processes. While deep learning (DL) based solutions have shown promise in streamlining adaptive radiation therapy (ART) workflows, they often require large and extensive datasets to train population-based models. Purpose: This study extends our prior research by introducing a minimalist approach to patient-specific adaptive dose prediction. In contrast to our prior method, which involved fine-tuning a pre-trained population model, this new method trains a model from scratch using only a patient's initial treatment data. This patient-specific dose predictor aims to enhance clinical accessibility, thereby empowering physicians and treatment planners to make more informed, quantitative decisions in ART. We hypothesize that patient-specific DL models will provide more accurate adaptive dose predictions for their respective patients compared to a population-based DL model. Methods: We selected 33 patients to train an adaptive population-based (AP) model. Ten additional patients were selected, and their respective initial RT data served as single samples for training patient-specific (PS) models. These 10 patients contained an additional 26 ART plans that were withheld as the test dataset to evaluate AP versus PS model dose prediction performance. We assessed model performance using Mean Absolute Percent Error (MAPE) by comparing predicted doses to the originally delivered ground truth doses. We used the Wilcoxon signed-rank test to determine statistically significant differences in terms of MAPE between the AP and PS model results across the test dataset. Furthermore, we calculated differences between predicted and ground truth mean doses for segmented structures and determined statistical significance in the differences for each of them. Results: The average MAPE across AP and PS model dose predictions was 5.759% and 4.069%, respectively. The Wilcoxon signed-rank test yielded two-tailed p-value = 2.9802 × 10 - 8 $2.9802\ \times \ {10}^{ - 8}$ , indicating that the MAPE differences between the AP and PS model dose predictions are statistically significant, and 95% confidence interval = [-2.1610, -1.0130], indicating 95% confidence that the MAPE difference between the AP and PS models for a population lies in this range. Out of 24 total segmented structures, the comparison of mean dose differences for 12 structures indicated statistical significance with two-tailed p-values < 0.05. Conclusion: Our study demonstrates the potential of patient-specific deep learning models in application to ART. Notably, our method streamlines the training process by minimizing the size of the required training dataset, as only a single patient's initial treatment data is required. External institutions considering the implementation of such a technology could package such a model so that it only requires the upload of a reference treatment plan for model training and deployment. Our single patient learning strategy demonstrates promise in ART due to its minimal dataset requirement and its utility in personalization of cancer treatment.

A Machine-Learning Model Using Artificial Neural Network to Facilitate Liver SBRT Prescription Selection by Predicting Normal Liver Geud Based on Geometric Properties of Liver and PTV

Automated Clinical Target Volume Delineation for Non-Small Cell Lung Cancer Patients Using Deep 3D Networks

Automated Clinical Target Volume Delineation Using Deep 3D Neural Networks in Radiation Therapy of Non-small Cell Lung Cancer

Estimation and Validation of Patient-Specific Liver Elasticity Distributions Derived from 4DMR for Radiotherapy Purposes

Dosimetric Analysis of Radiation Treatment Plans Based on a Deep Learning Auto Contouring Model for Patients with Localized Prostate Cancer

Uninvolved Liver Dose Prediction in Stereotactic Body Radiation Therapy for Liver Cancer Based on the Neural Network Method

A data-driven approach to optimal beam/arc angle selection for liver stereotactic body radiation therapy treatment planning

Predicting radiation pneumonitis in lung cancer: a EUD-based machine learning approach for volumetric modulated arc therapy patients

Deep-Learning-Based Dose Predictor for Glioblastoma–Assessing the Sensitivity and Robustness for Dose Awareness in Contouring

Modeling of Gamma Index for Prediction of Pretreatment Quality Assurance in Stereotactic Body Radiation Therapy of the Liver

Using deep learning to model the biological dose prediction on bulky lung cancer patients of partial stereotactic ablation radiotherapy

Single patient learning for adaptive radiotherapy dose prediction

Enhancing stereotactic ablative boost radiotherapy dose prediction for bulky lung cancer: A multi‐scale dilated network approach with scale‐balanced structure loss

Prediction of liver Dmean for proton beam therapy using deep learning and contour-based data augmentation

Nimg-74. A Novel Approach For Personalized Radiotherapy Target Volume Definition Using Metabolic Mri And Deep Learning-Driven Predictions Of Glioblastoma Recurrence

Toward automatic beam angle selection for pencil-beam scanning proton liver treatments: A deep learning-based approach

Large‐language‐model empowered 3D dose prediction for intensity‐modulated radiotherapy

Prediction of radiation induced liver disease using artificial neural networks.

Dosimetric Study of Deep Learning-Guided ITV Prediction in Cone-beam CT for Lung Stereotactic Body Radiotherapy

Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular Carcinoma

3D dose prediction for Gamma Knife radiosurgery using deep learning and data modification